Profile of the Medication Reconciliation Discrepancies in Oncology Patients: Integrative Literature Review

• Autor(a) principal: Sousa, Ana Rosa Navegantes de
• Data de Publicação: 2022
• Outros Autores: Tofani, Andrea Almeida, Martins, Carolina Lopes
• Tipo de documento: Artigo
• Idioma: por; eng
• Título da fonte: Revista Brasileira de Cancerologia (Online)
• Texto Completo: https://rbc.inca.gov.br/index.php/revista/article/view/1660
• topic: reconciliação de medicamentos; segurança do paciente; prática farmacêutica baseada em evidências; serviço hospitalar de oncologia; assistência farmacêutica; medication reconciliation; patient safety; evidence-based pharmacy practice; oncology service, hospital; pharmaceutical services; conciliación de medicamentos; seguridad del paciente; práctica farmacéutica basada en la evidencia; servicio de oncología en hospital; servicios farmacéuticos

Introduction: Cancer patient care requires actions of a multi-professional team due to the complexity of the treatment. One of the pharmacist’s services to contribute for the patient safety is the medication reconciliation, able to detect discrepancies in prescriptions and preventing medication errors. Objective: Draw a profile of the main discrepancies found in the literature in cancer patients during the practice of medication reconciliation performed by pharmacists. Additionally, a descriptive approach of the pharmaceutical interventions found in the studies was also attempted. Method: Integrative review of the literature with descriptors “Medication Reconciliation”, “Neoplasms”, “Pharmacists”, “Medication Errors” utilized to search in the following databases: PubMed, Web of Science, Embase and Scopus. Results: Initially, 141 articles were found and eleven were selected for discussion. Medication reconciliation was performed in patients at admission (27.3%), discharge from hospital (18.2%), and outpatient follow-up (54.5%). Observational Studies were the majority (72.7%) followed by intervention studies (27.3%). The main discrepancy reported was Omission/Need to add a medicine (81.5%). Pharmaceutical interventions were described in more detail in 36.4% of the publications. Conclusion: This study demonstrates the need for more articles that correlates the practice of medication reconciliation with the detection of discrepancies and pharmaceutical interventions in Oncology. Pharmacists should structure the practice of medication reconciliation in the clinical experience with cancer patients to improve their safety.